Skip to content
Shuttingdown

Repare Therapeutics Inc.

Pharmaceutical Preparations · SAINT-LAURENT

No longer listed

High confidence (85%)

Updated Sep 23, 2026, 12:05 AM

What is happening

Derived by rule set status-rules-2026.09.7

The company deregistered its securities and stopped filing with the SEC. Companies do that when they are acquired, when they go private, and when they fail; the filing does not say which.

Latest material event: Repare Therapeutics Inc. deregistered its securities (Feb 19, 2026)

Timeline

Every material event, newest first. History is never overwritten.

  1. Repare Therapeutics Inc. deregistered its securities

    Feb 19, 2026

    Registration withdrawn

    • SEC EDGAR — “15-12G 1 d76712d1512g.htm 15-12G 15-12G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. 001-39335 Commission File Number Repare Therapuetics Inc. (Exact name of registrant as specified in its charter) 2200 Powell Street, Suite 310 Emeryville, California 94608 (510) 204-7200 (Address, including zip code, and telephone number, including area code,…”

  2. Repare Therapeutics Inc. received a delisting notice from its exchange

    Jan 28, 2026

    Delisting notice received

    • SEC EDGAR — “Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. The information set forth under Item 2.01 of this Current Report on Form 8-K is incorporated herein by reference into this Item 3.01. In connection with the consummation of the Transaction, the Company (i) notified the Nasdaq Capital Market LLC ( Nasdaq ) of the consummation of the Transaction and (ii) requested that Nasdaq (A) suspend trading of the Shares effective after the closing of trading on January 28, 2026 and (B) file with the SEC a Notification of Removal from Listing and/o…”

  3. Repare Therapeutics Inc. was delisted from its exchange

    Jan 28, 2026

    Delisting effective

    • SEC EDGAR — “X0203 0001354457 Nasdaq Stock Market LLC 0001808158 Repare Therapeutics Inc. 001-39335 7171 FREDERICK BANTING SUITE 270, BUILDING 2 SAINT-LAURENT A8 QUEBEC, CANADA H4S 1Z9 (857) 412-7018 Common Shares 17 CFR 240.12d2-2(a)(3) Jennifer Fainer CDO Analyst 2026-01-28”

Company information

Founded
—
Employees (estimate)
—
Industry
Pharmaceutical Preparations
Subindustry
—
SEC CIK
0001808158
Website
—
LinkedIn
—
Headquarters
SAINT-LAURENT
Also known as
—
Legal entities
Repare Therapeutics Inc.

Sources

Every material source used to build this profile.

  • SEC Company Submissions (TIER 1 · UNVERIFIED)

    Repare Therapeutics Inc. — Pharmaceutical Preparations (SIC 2834) — SAINT-LAURENT, Quebec, Canada
    View source record

  • SEC EDGAR (TIER 1 · UNVERIFIED)

    15-12G 1 d76712d1512g.htm 15-12G 15-12G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. 001-39335 Commission File Number Repare Therapuetics Inc. (Exact name of registrant as specified in its charter) 2200 Powell Street, Suite 310 Emeryville, California 94608 (510) 204-7200 (Address, including zip code, and telephone number, including area code,…
    View source record

  • SEC EDGAR (TIER 1 · UNVERIFIED)

    X0203 0001354457 Nasdaq Stock Market LLC 0001808158 Repare Therapeutics Inc. 001-39335 7171 FREDERICK BANTING SUITE 270, BUILDING 2 SAINT-LAURENT A8 QUEBEC, CANADA H4S 1Z9 (857) 412-7018 Common Shares 17 CFR 240.12d2-2(a)(3) Jennifer Fainer CDO Analyst 2026-01-28
    View source record

  • SEC EDGAR (TIER 1 · UNVERIFIED)

    Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. The information set forth under Item 2.01 of this Current Report on Form 8-K is incorporated herein by reference into this Item 3.01. In connection with the consummation of the Transaction, the Company (i) notified the Nasdaq Capital Market LLC ( Nasdaq ) of the consummation of the Transaction and (ii) requested that Nasdaq (A) suspend trading of the Shares effective after the closing of trading on January 28, 2026 and (B) file with the SEC a Notification of Removal from Listing and/o…
    View source record

Status history

Every derived status, with the rule that produced it.

  • DISTRESS_SIGNAL → NO_LONGER_LISTEDPUBLIC_LISTING_ENDED · Sep 18, 2026, 01:30 AM

    The company deregistered its securities and stopped filing with the SEC. Companies do that when they are acquired, when they go private, and when they fail; the filing does not say which.

  • DISTRESS_SIGNAL → DISTRESS_SIGNALLISTING_STANDARDS_WARNING · Sep 18, 2026, 01:14 AM

    An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.

  • DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 15, 2026, 12:35 PM

    The company stopped being publicly listed. That happens to failing companies and to acquired ones alike.

  • DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 14, 2026, 04:46 PM

    The company stopped being publicly listed. That happens to failing companies and to acquired ones alike.

  • UNKNOWN → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 8, 2026, 04:00 AM

    The company stopped being publicly listed. That happens to failing companies and to acquired ones alike.

  • UNKNOWN → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 8, 2026, 04:00 AM

    The company stopped being publicly listed. That happens to failing companies and to acquired ones alike.